Healthcare Distribution Alliance – Patients Move Us.
Share Print



Results: 5 Articles found.
  • Three Takeaways from the FDA Public Meetings on DSCSA
    March 26, 2018

    On February 28, FDA hosted its third and final public meeting in a series focused on "Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act [DSCSA],” bringing together a broad group of stakeholders, including manufacturers, distributors, dispensers, hospitals and service providers.

  • Building on Role as a Convener, HDA Launches Allied Against Opioid Abuse
    March 14, 2018

    As the logistics experts of healthcare, pharmaceutical distributors play a critical role in the day-to-day operations of the supply chain, but also when health challenges arise, such as a natural disaster or shortages in medicines.

  • The Opioid Epidemic Requires A Greater Focus on Education and Awareness
    March 2, 2018

    As the country looks to reverse the harmful trend of opioid addiction, the need for education and awareness around the safe use of pain treatments has never been clearer.

  • Transitioning to Traceability — and a Verification Router Service Update
    February 16, 2018

    As an organization, HDA has been looking for new ways to communicate the work happening around DSCSA implementation with a broader audience beyond twice a year at our Traceability Seminar and Distribution Management Conference. Beginning this month, the HDA blog is expanding to feature traceability/Drug Supply Chain Security Act (DSCSA) updates as well as HDA perspectives on a variety of related issues throughout the year.

  • HDA President and CEO John M. Gray Outlines 2018 Alliance Priorities in Chain Drug Review
    January 8, 2018

    Efforts to mitigate the prescription drug abuse epidemic and activities surrounding DSCSA implementation once again top the list of priorities HDA will be addressing in the year ahead, according to HDA President and CEO John M. Gray. Mr. Gray provided his perspective, along with other healthcare supply chain leaders, as part of Chain Drug Review’s annual “Pharmacy Outlook” feature, published in the January 1 issue.

Website design and development by, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | O365